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Abstract
The objective of the study was to review current literature to determine whether the topical
application of platelet-rich plasma (PRP) promotes healing in experimentally-induced full-
thickness skin wounds in animals. The hypothesis was that the adjunct of PRP has a posi-
tive effect on wound healing. An electronic search was carried out on the following data-
bases: Web of Science, Cochrane Library, PubMed, Research Gate, Cochrane Wounds
Group, Veterinary Information Network. No publication date nor language restrictions were
applied. Randomised and not randomised controlled clinical trials comparing PRP with pla-
cebo or with other treatments were included. The reduction of open wound area in PRP-
treated (test) wounds compared to control wounds was the primary outcome. Secondary
outcomes were healing time and number of healed cases in test group compared to control.
The following effect sizes were calculated: the Hedges’ g for continuous variables; the odds
ratio for binary data. Eighteen controlled clinical trials were included in the qualitative and
quantitative synthesis, with a total of 661 wounds. All studies were published in the period
2007–2016. Eight studies were carried out on rodent/lagomorph mammals and 10 on non-
rodent/lagomorph mammals. In all included studies, control wounds underwent placebo or
were left untreated. The PRP group showed a better healing performance than the control
group in each outcome. The effect size was statistically significant considering the primary
outcome and the overall aggregation of the three outcomes. The effect size, although in
favour of the treatment with PRP, was not significant considering the healing time and the
number of healings. The overall heterogeneity was mild or moderate. Five studies reported
a high risk of selection bias. The publication bias was always mild or absent. The results
support the hypothesis of the positive effects of the PRP when compared to control groups
in the treatment of experimentally-induced full-thickness skin wounds in animals. PRP can
therefore be considered an effective adjunctive therapy in stimulating second intention heal-
ing of acute wounds in healthy animals.
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Introduction
The wound healing process is usually divided into three main phases: the inflammatory phase,
the proliferative phase, and tissue remodeling. These events are regulated by a complex inter-
action of molecular signals involving mediators, primarily cytokines and growth factors (GFs).
The GFs stimulate and modulate the major cellular activities involved in the healing process.
In chronic wounds, the normal progression is disrupted and slowed down, so that healing dif-
ficulties arise [1–5].
Platelets play a fundamental role in the healing process of skin wounds. The platelet-derived
GFs are particularly important during the proliferation phase (fibroplasia, reepithelialisation
and neovascularisation), as they are involved in the recruitment of mesenchymal cells, and in
the synthesis of the extracellular matrix [4–8].
Following spontaneous or induced activation, platelets release the GFs contained in the
alpha granules, including: Platelet-Derived Growth Factor (PDGFαα/ββ/αβ), Transforming
Growth Factor β1/2 (TGF-β1/2), Vascular Endothelial Growth Factor (VEGF), Basic Fibro-
blast Growth Factor (bFGF), Platelet-Derived Epidermal Growth Factor (PDEGF), Insulin-
like Growth Factor-I/II (IGF-I/II) [9,10].
Platelet-Rich Plasma (PRP) is a platelet concentrate that is applied locally at the injury site,
upon activation. In recent years, different preparation protocols and activating agents have
been proposed. All the following substances are considered activating agents: bovine throm-
bin/thromboplastin, agonist peptide of the thrombin receptor, ITA gelling agent (NATREX
Technologies, Inc., Greenville, NC), batroxobin (clotting enzyme isolated from the venom of
the snake Bothrops atrox, belonging to the Viperidae family), calcium chloride (CaCl2), ascor-
bic acid and autologous thrombin [8,11–16]. Using different methods of preparation, two
types of PRP can be obtained: PRP with the presence of leukocytes (L-PRP) and pure PRP
(P-PRP), without leukocytes [17–19].
In the recent years the positive effect of PRP for healing enhancement has been reported in
many applications of human medicine: skin ulcers (bedsores and diabetic ulcers), plastic-
reconstructive and cosmetic surgery [1,8,10,20,21,22,23]; oral-maxillofacial surgery [10,22];
cartilage and tendon repair [10,22]; orthopaedic surgery and bone reconstruction (e.g. delayed
union, nonunion, ischemic osteonecrosis, osteolysis, tendon-muscular diseases) [10,22,24,25];
and ophthalmology (corneal ulcers) [10,22]. Despite the growing interest, the scientific litera-
ture is still limited in veterinary medicine, where a paucity of randomised clinical trials can be
observed [12,26–35].
Before designing clinical studies on large human and animal populations with spontaneous
disease, there is the need to assess the evidence of the literature regarding the application of
PRP in experimentally-induced wounds in animals.
The objective of the study was to review current literature in order to determine whether
topical application of PRP promotes the healing process in experimentally-induced full-thick-
ness skin wounds in animals. The hypothesis was that the adjunct of PRP, compared with pla-
cebo or with other treatments, has a positive effect on wound healing.
Methods
In this systematic review, the principles of the PRISMA guidelines (Preferred Reported Items
for Systematic Review and Meta-analyses) [36,37] and the Cochrane Handbook for Systematic
Reviews of Interventions [38] were followed. A step-by-step systematic review protocol was
deposited in protocols.io (dx.doi.org/10.17504/protocols.io.k5rcy56).
PRP for skin wound healing in animals
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Criteria for considering studies for this review (Study eligibility criteria)
To define the criteria for inclusion of each primary study, a structured approach type PICOS
(Population, Intervention, Comparison, Outcomes, Study design) was used. Below, the main
features are described.
Randomised and non-randomised controlled clinical trials (CCTs) that compared PRP
with other treatments or placebo were considered.
The population under study consisted of animals of all species, breed and age, on which
full-thickness skin wounds were experimentally induced, and left to heal by secondary
intention.
Studies that compared PRP (produced by any method) with placebo or with other topical
therapies such as standard care or biomaterials were eligible for this systematic review.
The primary outcome was represented by the reduction in size of open wound area in the
PRP treated wounds compared to the size reduction in control wounds (reported in primary
studies as: the percentage of reduction of wound area compared with baseline; the percentage
of open wound area, or not healed, or not re-epithelialized, compared to the admission; the
absolute wound area expressed in cm2).
The secondary oucomes consisted of:
• healing time (time needed to obtain the complete healing of the wound in PRP treated
wounds compared to controls);
• number of healings (proportion of wounds showing complete healing in PRP treated
wounds compared to controls).
Any reference to the assessment of wound complications, wound pain, quality of life and
adverse events related to the intervention was also sought.
Criteria for considering publications for this review (Report eligibility
criteria)
No restriction was placed regarding language and publication date. Only studies published on
indexed, peer-reviewed Journals were considered.
Search methods for identification of studies
The literature search was conducted with broad search criteria, so as to limit the number of
false negatives (relevant studies but not found during the search phase), while increasing the
number of false positives (studies found during the search phase that do not truly meet the
inclusion criteria) [39].
The electronic search was undertaken on the following databases: Web of Science,
Cochrane Library, PubMed, Research Gate, Cochrane Wounds Group, Veterinary Informa-
tion Network (VIN).
In the aforementioned databases, the search was done using the following keywords, com-
bined using the Boolean operators AND, OR:
• platelet / platelet-rich / platelet-rich plasma / platelet gel;
• wound / skin / ulcer;
• animal / dog (canine) / horse (equine) / pig (swine) / goat (caprine) / sheep (ovine) / cow
(cattle, bovine) / cat (feline) / rabbit (cunicola) / mouse (mice, murine) / rat.
PRP for skin wound healing in animals
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When it was necessary to obtain additional information, especially in cases of incomplete
data, the authors of the clinical studies were contacted directly.
Data collection and analysis
Selection of studies. The screening was performed by two independent reviewers (AMT,
MDF). All identified studies were assessed by the inclusion/exclusion criteria then subjected to
the screening phase. First of all, duplicates emerging from one or more search strategies and
databases have been excluded.
The records screened were selected using a two-step approach, first by analyzing the title
and abstract (with identification of the # of records excluded), then by analyzing the full-text
(with identification of the # of full-text articles assessed for eligibility). The reason for exclu-
sion was specified for each of the excluded references (# of full-text articles excluded, with
reasons).
Finally, the identified studies were classified as included in the systematic review (# of stud-
ies included in the qualitative synthesis) and in the meta-analysis (# of studies included in the
quantitative synthesis—meta-analysis) thus completing the PRISMA flow diagram.
Data extraction and management. The following data from each included primary study
were extracted and recorded in a data extraction form:
• study characteristics (name, design, country, funding source);
• publication characteristics (year, language, type);
• participants’ characteristics (number, species);
• characteristics of induced lesions (size and number of wounds, induction mode);
• intervention characteristics (PRP production technique, platelet concentration);
• treatment protocol (division into groups and groups description, randomisation, number of
PRP applications, frequency of applications, bandage);
• assessments carried out in primary studies (outcome measures, the presence of multiple
time points or waves);
• main results of primary studies.
Assessment of risk of bias in included studies. The risk of bias assessment was based on
the guidance in the Cochrane Handbook of Systematic Reviews of Intervention [38].
The adequacy of the method used to generate the allocation sequence (random sequence
generation, selection bias), the method of allocation concealment (allocation concealment,
selection bias), the level of blinding (blinding of outcome assessment, detection bias), the pres-
ence of incomplete outcome data (attrition bias), and the defect in the reproduction of results
(selective reporting, reporting bias) were examined.
Measures of treatment effect. For outcomes represented by continuous variables (reduc-
tion in size of the wound area, healing time), to statistically measure the effect size (ES), the
Hedges’ g was used. It was calculated starting from the Cohen’s d, using the correction coeffi-
cient J.
As data entry format arising from primary studies, mean values, standard deviations, and
the sample size of both groups were preferentially used (gold data entry format). If the
PRP for skin wound healing in animals
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preferential data entry format was not represented in primary studies, a hierarchical scale for
data entry format was established, as described below:
1. mean values, standard deviations, and the sample size;
2. mean values, t-value (result of t-test), sample size;
3. mean values, statistical significance (p-value), sample size;
4. t-value, sample size;
5. p-value, sample size.
For binary outcome data (number of healings), to statistically measure the ES, the odds
ratio (OR) was used. To calculate the OR the number of subjects healed (event) and the total
sample size of each group for each study was used as gold data entry format.
The unit of analysis was the single wound.
The authors of primary studies were contacted in order to obtain additional information
where data were missing or unclear.
Management of complex meta-analytical databases. In case of detection in primary
studies of complex meta-analytical databases, such as independent subgroups, multiple out-
comes, multiple comparisons, multiple time points (waves), the complexity of data was main-
tained in the analysis wherever possible in order to provide the most accurate possible
synthesis. Otherwise, the possibility of performing a pre-analysis for each complex database
was considered. The pre-analysis permitted the choice between two options: carry out the anal-
ysis separately by calculating an ES for each complex database, or aggregate the various meta-
data to obtain a unique effect.
Assessment of heterogeneity. The presence of heterogeneity was assessed with the Q
homogeneity test, in order to assess whether the meta-analysis was characterised by significant
heterogeneity. The impact of heterogeneity was statistically quantified using the I2.
The I2 value was interpreted on the basis of the cut-off proposed by Higgins et al., according
to which values equal to 25%, 50% and 75% respectively indicating low, moderate and high lev-
els of heterogeneity [40,41].
Assessment of reporting biases. The publication bias assessment was performed using
the funnel plot. The symmetry of the funnel plot was statistically tested with Egger’s linear
regression method. To compare the observed ES and the estimated ES in the absence of publi-
cation bias, the Trim and Fill method was used (the absence of difference between the two
types of effect size indicated an absence of risk of publication bias, a minimum difference min-
imal risk, and so on).
Data synthesis. Any statistical analyses of metadata were performed with software Pro-
Meta version 2 (Internovi, Cesena, Italy).
Analysis of the moderators and evaluation of heterogeneity. To assess the possible het-
erogeneity of the studies, in order to explain which factors might affect it, potential moderators
of the results obtained have been considered and analyzed, in particular: country (recodified
to: Asia, Europe, North America, South America); animal species (recodified to: rodents/lago-
morphs and non rodents/lagomorphs.); initial wound size ( and< 1 cm2); funding source
(for profit funding, for non-profit funding and no-funding statement); n. of spinning cycles
for PRP production (single or double spin); activation (application and non-application of
activation procedures); platelet concentration in PRP ( and< 106 plt/microL); n. of treat-
ments (single treatment and multiple treatment).
Sensitivity analysis. For each meta-analysis project, a sensitivity analysis was carried out
by performing the meta-analysis, by excluding one study at a time.
PRP for skin wound healing in animals
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Results
Description of studies
The research performed in the bibliographic databases and references of primary studies
identified 1922 documents. After removing duplicates, the first screening based on title and
abstract provided 41 eligible studies. The full-text assessment of such studies allowed inclusion
of 18 primary studies in both qualitative and quantitative synthesis (meta-analysis) [30,42–58].
(Fig 1)
A total of 661 experimental wounds were considered in this systematic review, with an aver-
age of 36.72±37.69 wounds/study (range 8-180/study).
In all included studies, wounds were created by full-thickness skin excision; control wounds
underwent placebo (saline solution or milli-Q-water) or were left untreated; treated wounds
received L-PRP application. Treated and control wounds were dressed with the same bandage
technique.
The main characteristics of primary studies are reported in Table 1.
After full-text evaluation, 23 studies were excluded. These are listed in Table 2, along with
the reason for their exclusion [12,26,27,32,33,35,59–75].
Risk of bias in included studies
Five included studies presented a high risk of selection bias: the result was based on the fact
that the allocation of the group was not carried out in a randomised fashion. Only one study
reported information on blinding of the evaluators. (Fig 2)
No independent subgroups or multiple comparisons were identified in the included studies,
while multiple outcomes and multiple time points (wave) were identified.
For multiple outcomes a conservative approach was adopted, considering the individual
outcomes, the results of which are described in the Effects of intervention, meta-analyses 1–3,
Figs 3 to 9. The subsequent outcome aggregation is described in the Effects of interventions,
meta-analysis 4, Figs 10 to 12.
Before deciding the method to analyse the multiple time points, a pre-analysis was per-
formed to compare the results of the individual waves. The pre-analysis showed that the results
of the various waves were similar to each other (ANOVA Q random effect model tests,
Q = 3.39, df = 8, P = 0.908), therefore the data of the different waves were combined in meta-
analyses.
Effect of interventions
1) Reduction of open wound area in PRP treated wounds compared to controls (pri-
mary outcome). Fifteen primary studies, considering a total of 549 wounds, reported data on
this outcome.
Assessing the reduction in size of open wound area, there was a statistically significant
advantage of the PRP-treated group against the control group.
The significance of Q index indicates the presence of heterogeneity among the included
studies; the I2 index indicates a moderate grade of heterogeneity. (Fig 3)
Although the forest plot in Fig 3 showed two studies with not significant negative ES
[51,53], two studies with null ES [30,46], seven studies with not significant positive ES
[42,44,45,50,52,56,58] and four studies with significant positive ES [43,54,55,57]: the exclusion
of each of the studies, in the sensitivity analysis, would have no relevant effect on the overall
results of the meta-analysis supporting the efficacy of PRP for primary outcome. (Fig 4)
PRP for skin wound healing in animals
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Fig 1. Selection of primary studies: PRISMA flow diagram.
https://doi.org/10.1371/journal.pone.0191093.g001
PRP for skin wound healing in animals
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The symmetry of the funnel plot, demonstrated statistically by the non-significance of
Egger’s linear regression method, associated with the absence of trimmed studies and the over-
lap between the observed overall ES with the estimated overall ES, showed that the results are
not affected by risk of publication bias. (Fig 5)
Table 1. Characteristics of the included studies in alphabetical order.
Primary Studies GD FS AS NW WS WD MW MP MA PC NT
[42] Abegão 2015 SA NFS RL 12 50.2 FT Punch DS - NR 2
Brazil (rabbit)
[43] Al-Bayati 2013 AS NS NRL 40 900.0 FT Blade DS CaCl2 < 1
Iraq (goat)
[44] Barrionuevo 2015 SA NFS RL 12 50.2 FT Punch DS CG NR 1
Brazil (rabbit)
[45] Bauer 2009 SA NS RL 8 19.6 FT 2mm Punch SS CaCl2 < 1
Brazil (rat)
[46] Blanton 2009 NA P NRL 48 150.0 FT 7.9mm Blade SS T/TP
CaCl2
< 1
USA (pig) ep,de,sc
[47] De Souza 2015 SA NP NRL 28 625.0 FT Blade DS - < 1
Brazil (horse) ep,de,sc
[48] Dionyssiou 2013 EU P RL 40 400.0 FT Blade SS -  1
Greece (rabbit)
[49] Hadad 2010 NA P NRL 36 150.0 FT 4mm - SS T/TP
CaCl2
< 1
USA (pig)
[50] Jee 2016 AS NS NRL 24 28.3 FT Punch SS -  2
Korea (dog) ep,de
[51] Karayannop. 2015 EU P NRL 36 400.0 FT - SS -  1
Greece (dog)
[52] Lee 2008 NA NP RL 30 625.0 FT Blade SS T/TP
CaCl2
NR 1
USA (rabbit) ep,de,sc
[53] Monteiro 2009 EU NP NRL 24 625.0 FT Blade SS T/TP
CaCl2
NR 2
France (horse) ep,de,sc
[54] Nisbet 2009 AS NS RL 30 225.0 FT Blade DS T/TP
CaCl2
 2
Turkey (rabbit) ep,de,sc
[55] Notodihardjo 2014 AS NP RL 180 28.3 FT Punch DS CaCl2  1
Japan (mouse) ep,de,sc
[30] Sardari 2011 AS NP NRL 30 400.0 FT - DS T/TP
CaCl2
< 2
Iran (dog)
[56] Vermeulen 2009 EU NS NRL 21 400.0 FT 1cm Blade DS T NR 1
Belgium (pig) ep,de,sc
[57] Yan 2007 NA P NRL 48 226.9 FT 5mm Punch DS T/TP
CaCl2
NR 1
USA (pig)
[58] Yang 2011 Asia NP RL 14 400.0 FT Scissor DS - NR 1
Korea (mouse) ep,de,sc
GD: Geographical distribution; SA: SouthAmerica; NA: NorthAmerica; EU: Europe; AS: Asia; FS: Funding source; P: for profit funding; NP: for non-profit funding;
NFS: no-funding statement; NS: no statement regarding the funding source; AS: Animal species; RL: rodent/lagomorph mammals; NRL: non-rodent/lagomorph
mammals; NW: Number of wounds; WS: Initial wound size (mm2); WD: Wound depth; FT: full-thickness; ep: epidermidis; de: dermis; sc: subcutaneous tissue; MW:
Method of wounding; MP: Method of PRP production; SS: single spin; DS: double spin; MA: Method of PRP Activation; CG: Calcium Gluconate; T: Thrombin; TP:
Thromboplastin; PC: Platelet concentration;<: platelet concentration< 106 plt/microL;: platelet concentration 106 plt/microL; NR: not reported. NT: Number of
treatments
https://doi.org/10.1371/journal.pone.0191093.t001
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2) Healing time in PRP treated wounds compared to controls. Four primary studies,
considering a total of 116 wounds, reported data on this outcome.
Considering the healing time, there was no statistical difference between the study groups.
Two studies showed not statistical negative ES [47,53]; two studies showed positive ES [48,50]
among which one with significative statistical difference [48].
The significance of Q index indicates that heterogeneity is present in the primary studies;
the I2 index indicates a high level of heterogeneity. (Fig 6)
Sensitivity analysis did not influence the overall result of the meta-analysis 2, persisting a
lack of statistical difference between study groups. (Fig 7)
The symmetry of the funnel plot, demonstrated statistically by the non-significance of
Egger’s linear regression method, associated with the absence of trimmed studies and the over-
lap between the observed overall ES with the estimated overall ES, showed that the results are
not affected by risk of publication bias. (Fig 8)
3) Number of healings in PRP treated wounds compared to controls (number of
wounds showing complete healing). Two primary studies, considering a total of 76 wounds,
reported data on this outcome.
Considering the number of wound healings on the total sample size (proportion of healing)
a situation of high heterogeneity was found, as evidenced by the Q and I2 indices.
The study Dionyssiou 2013 [48] was statistically in favour of treatment with PRP, while the
study Hadad 2010 [49] showed a slight favour, although not statistically significant, for the
control group. (Fig 9)
Table 2. Characteristics of excluded studies in alphabetical order.
Studies Reasons for exclusion
[12] Carter et al, 2003 Histological study
[59] Chung et al, 2015 Case report
[26] DeRossi et al, 2009 Histological study; sutured wounds, primary intention healing
[60] Demidova-Rice et al, 2012 Histological and biomolecular study
[61] Ferdousy et al, 2013 Histological study; sutured wounds, primary intention healing
[62] Henderson et al, 2003 Experimental lesions consist of burns and not by full-thickness wounds
[63] Hermeto et al, 2012 The study considered skin grafts; lack of data to calculate the ESe
[32] Iacopetti et al, 2012 Case report
[27] Kim et al, 2009 Case report
[64] Koempel et al, 1998 Experimental lesions on tracheal mucosa
[65] Lian et al, 2014 Lack of data needed to calculate the effect size
[66] Lo´pez et al, 2014 Case report
[33] Maciel et al, 2012 Microscopic evaluation; lack of data needed to calculate the effect size
[67] Molina-Minao et al, 2009 Sutured wounds, primary intention healing
[68] Ostvar et al, 2015 Lack of data needed to calculate the effect size
[69] Pietramaggiori et al, 2006 Histological and immunohistochemical study
[70] Pietramaggiori et al, 2008 Lack of data needed to calculate the effect size
[71] Sell et al, 2012 In-vitro study
[72] Shayesteh et al, 2012 Experimental lesions on palatal mucosa
[35] Tambella et al, 2014 Spontaneous lesions, not experimentally induced
[73] Tsuzuki et al, 2012 Experimental lesions on epithelium soleare
[74] Vijayaraghavan et al, 2014 Retrospective study
[75] Zubin et al, 2015 Case report
https://doi.org/10.1371/journal.pone.0191093.t002
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Fig 2. Risk of bias summary. Review author’s judgement obtained by each included study for each type of bias.
https://doi.org/10.1371/journal.pone.0191093.g002
PRP for skin wound healing in animals
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As only two studies considered this outcome (meta-analysis 3: Number of healings), the
sensitivity analysis (without providing any additional information) proved to be in full agree-
ment with the forest plot.
The publication bias analysis was not possible for this outcome due to the low number of
studies.
4) Combination of all outcomes. Considering the aggregation of all outcomes of this
meta-analysis (primary and secondary) a statistically significant difference between the two
experimental groups appeared (95% CI 0.16,0.64; P = 0.001). PRP treatment generally proved
to be more effective in stimulating the healing process of experimental wounds in animals.
The overall effect size (= 0.40), interpreted with Cohen’s cut-off values [39], indicated a
medium effect size.
Fig 3. Forest plot: PRP vs control, meta-analysis 1: Reduction of open wound area (negative ES, positioned on the left of the null value:
favours control; positive ES, positioned on the right of the null value: favours PRP). Heterogeneity analysis: Q = 39.35; df = 14; P = 0.000; I2
= 64.42; T2 = 0.14; T = 0.37. (ES: effect size; 95%CI: confidence interval; W: weight; V: variance; SE: standard error; Sig: statistical significance
(p-value); N: total sample size; N1: sample size PRP group; N2: sample size control group; Q, I2, T2 and T: indexes of heterogeneity; df: degrees
of freedom).
https://doi.org/10.1371/journal.pone.0191093.g003
Fig 4. Sensitivity analysis, meta-analysis 1: Reduction of open wound area. (ES: effect size; 95%CI: confidence interval; W: weight; V:
variance; SE: standard error; Sig: statistical significance (p-value); N: total sample size; N1: sample size PRP group; N2: sample size control
group).
https://doi.org/10.1371/journal.pone.0191093.g004
PRP for skin wound healing in animals
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Fig 5. Publication bias analysis, funnel plot, meta-analysis 1: Reduction of open wound area. Trim and fill analysis:
trimmed studies = 0. Overall effect size (observed): ES = 0.40; LL = 0.16; UL = 0.65; P = 0.001; V = 0.02; SE = 0.13.
Overall effect size (estimated): ES = 0.40; LL = 0.16; UL = 0.65; P = 0.001; V = 0.02; SE = 0.13. Egger’s linear regression
test: intercept = 0.60; t = 0.52; P = 0.611.
https://doi.org/10.1371/journal.pone.0191093.g005
Fig 6. Forest plot: PRP vs control, meta-analysis 2: Healing time (negative ES, positioned on the left of the null value: favours control;
positive ES, positioned on the right of the null value: favours PRP). Heterogeneity analysis: Q = 13.69; df = 3; P = 0.003; I2 = 78.09; T2 = 0.50;
T = 0.71. (ES: effect size; 95%CI: confidence interval; W: weight; V: variance; SE: standard error; Sig: statistical significance (p-value); N: total
sample size; Q, I2, T2 and T: indexes of heterogeneity; df: degrees of freedom).
https://doi.org/10.1371/journal.pone.0191093.g006
Fig 7. Sensitivity analysis, meta-analysis 2: Healing time. (ES: effect size; 95%CI: confidence interval; W: weight; V: variance; SE: standard
error; Sig: statistical significance (p-value); N: total sample size; N1: sample size PRP group; N2: sample size control group).
https://doi.org/10.1371/journal.pone.0191093.g007
PRP for skin wound healing in animals
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The significance of the Q index indicated the presence of heterogeneity among the included
studies; the I2 index indicated that heterogeneity was moderate. (Fig 10)
The sensitivity analysis showed that the hypothetical exclusion of each one of the experi-
mental studies would not alter the overall results of the meta-analysis performed by combining
all the outcomes, in agreement with the hypothesis of favour for the PRP. (Fig 11)
The symmetry of the funnel plot, demonstrated statistically by the non-significance of
Egger’s linear regression method, associated with the absence of trimmed studies and the over-
lap between the observed overall ES and the estimated overall ES, showed that the results are
not affected by risk of publication bias. (Fig 12)
Effect of moderators
The moderator with the greatest influence on the observed heterogeneity was the platelet con-
centration in the PRP. The platelet concentration recodified from numeric moderator (mean
number of platelets/microL) to categorical moderator (mean number of platelets < or to
Fig 8. Publication bias analysis, funnel plot, meta-analysis 2: Healing time. Trim and fill analysis: trimmed
studies = 0. Overall effect size (observed): ES = 0.10; LL = -0.68; UL = 0.89; P = 0.795; V = 0.16; SE = 0.40. Overall
effect size (estimated): ES = 0.10; LL = -0.68; UL = 0.89; P = 0.795; V = 0.16; SE = 0.40. Egger’s linear regression test:
intercept = -21.36; t = -2.66; P = 0.117.
https://doi.org/10.1371/journal.pone.0191093.g008
Fig 9. Forest plot: PRP vs control, meta-analysis 3: Number of healings (negative ES, positioned on the left of the null value: favours
control; positive ES, positioned on the right of the null value: favours PRP). Heterogeneity analysis: Q = 7.59; df = 1; P = 0.006; I2 = 86.82;
T2 = 1.68; T = 1.30. (ES: effect size; 95%CI: confidence interval; W: weight; V: variance; SE: standard error; Sig: statistical significance (p-value);
N: total sample size; N1: sample size PRP group; N2: sample size control group; Q, I2, T2 and T: indexes of heterogeneity; df: degrees of
freedom).
https://doi.org/10.1371/journal.pone.0191093.g009
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1x106/microL) showed a significant difference between the two categories in influencing the
effect size, since a concentration of platelets in the PRP 1x106/microL had a significantly
higher effect size (Q = 3.49, P = 0.026). (Table 3)
No significant difference in the effect was found for country recodified (Q = 1.48;
P = 0.688), animal species recodified (Q = 5.01; P = 0.125), initial wound size recodified
(Q = 0.01, P = 0.907), funding source (Q = 1.10; P = 0.577), number of spinning cycles
(Q = 1.45; P = 0.228), activation procedures (Q = 0.00; P = 0.944), number of treatments
(Q = 0.06; P = 0.800). (Table 3)
Fig 10. Forest plot: PRP vs control, meta-analysis 4: Combination of all outcomes (negative ES, positioned on the left of the null value:
favours control; positive ES, positioned on the right of the null value: favours PRP). Heterogeneity analysis: Q = 50.87; df = 17; P = 0.000;
I2 = 66.58; T2 = 0.16; T = 0.40. (ES: effect size; 95%CI: confidence interval; W: weight; V: variance; SE: standard error; Sig: statistical significance
(p-value); N: total sample size; Q, I2, T2 and T: indexes of heterogeneity; df: degrees of freedom).
https://doi.org/10.1371/journal.pone.0191093.g010
Fig 11. Sensitivity analysis, meta-analysis 4: Combination of all outcomes. (ES: effect size; 95%CI: confidence interval; W: weight; V:
variance; SE: standard error; Sig: statistical significance (p-value); N: total sample size; N1: sample size PRP group; N2: sample size control
group).
https://doi.org/10.1371/journal.pone.0191093.g011
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Complications and adverse events during wound healing process
In the control group of a primary study performed on rabbits [48], a clear clinical deterioration
was found in 6 of 20 wounds, undergoing a deepening of the wound floor gradually developing
into full thickness perforations of the ear pinna; in the PRP group, only one case out of 20
showed delayed healing, in the absence of other complications.
In a primary study performed on horses [53], in the PRP group (7 wounds of 12) a greater
tendency to develop exuberant granulation tissue was shown in comparison to the control
group (2 of 12 wounds). In addition, the wounds of the PRP group showing this complication
needed an average of 3.0 ± 1.37 excisions of exuberant granulation tissue, while in the control
group an average of 0.5 ± 0.84 excisions was practiced. However, this difference was not statis-
tically significant (P = 0.19).
No study reported on assessment of pain resulting from injury, life quality, adverse events
related to the intervention.
Discussion
Summary of main results and quality of the evidence
Based on the growing interest of the scientific community in regenerative medicine, the last
few decades have witnessed a significant increase in the number of studies performed both in
vitro and in vivo. These studies have been conducted to develop and validate therapeutic aids,
such as PRP, which can potentially influence the natural reparative capacity of tissue. The pres-
ent systematic review continues this trend, with its purpose to determine if topical application
of PRP is able to promote the healing process of experimentally-induced wounds in animals.
Fig 12. Publication bias analysis, funnel plot, meta-analysis 4: Combination of all outcomes. Trim and fill analysis:
trimmed studies = 0. Overall effect size (observed): ES = 0.40; LL = 0.16; UL = 0.64; P = 0.001; V = 0.01; SE = 0.12.
Overall effect size (estimated): ES = 0.40; LL = 0.16; UL = 0.64; P = 0.001; V = 0.01; SE = 0.12. Egger’s linear regression
test: intercept = 0.63; t = 0.57; P = 0.577.
https://doi.org/10.1371/journal.pone.0191093.g012
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Table 3. Assessment of the moderators’ effect on the combined overall outcome.
k N1 N2 Hedge’s g
[95% CI]
Sig.
Q
Sig.
I2 Contrast Q
Sig.
Country recodified 1.48
0.688
Asia 6 159 159 0.57 14.48 65.46
[0.22,0.92] 0.013
0.001
Europe 4 58 63 0.33 18.57 83.85
[-0.49,1.15] 0.000
0.43
North America 4 81 73 0.33 9.69 69.05
[-0.19,0.86] 0.021
0.211
South America 4 30 30 0.25 3.31 9.45
[-0.17,0.67] 0.346
0.238
Animal species recodified 5.01
0.125
Non rodents/lagomorphs 10 169 166 0.18 23.26 61.90
[-0.11,0.47] 0.005
0.233
Rodents/lagomorphs 8 159 159 0.72 18.62 62.40
[0.35,1.10] 0.009
0.000
Initial wound size recodified 0.01
0.907
< 1 cm2 5 118 118 0.41 1.42 0.000
[0.21,0.61] 0.840
0.000
 1 cm2 13 210 207 0.39 49.12 75.57
[0.05,0.73] 0.000
0.026
Funding Source 1.10
0.577
No funding 2 12 12 0.36 0.82 0.000
[-0.18,0.90] 0.364
0.196
Non-Profit 6 149 149 0.12 11.43 56.24
[-0.23,0.47] 0.044
0.514
Profit 5 108 100 0.44 21.55 81.44
[-0.15,1.02] 0.000
0.142
N. of spin 1.45
0.228
Double spin 10 205 210 0.53 22.95 60.78
[0.24,0.83] 0.006
0.000
(Continued)
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The extensive literature search, performed using a variety of different bibliographic data-
bases, shows that the studies included in this review are all very recent, having been published
from 2007 to 2016 (28% of them in 2015–2016).
The studies referenced were conducted all over the world, including emerging countries
from a scientific point of view, such as Asian countries, which by the way are those that
achieved the best results with PRP treatment. Brazil presents the same number of studies
(four) as the United States of America (USA). Finally, the European countries, all together,
present the same frequency as Brazil and USA.
Regarding the geographical distribution of the financed studies, the studies reporting
sources of funding were performed in the USA (3 for profit; 1 non-profit), Greece (2 for
profit), France (1 non-profit), Brazil (1 non-profit) and Asia (Japan, Iran, Korea, each with 1
non-profit).
During the systematic review, two types of complex meta-analytical database were detected:
multiple outcomes and multiple time points.
Table 3. (Continued)
k N1 N2 Hedge’s g
[95% CI]
Sig.
Q
Sig.
I2 Contrast Q
Sig.
Single spin 8 123 115 0.24 21.18 66.95
[-0,15,0.62] 0.004
0.232
Activation procedures 0.00
0.944
No activation 6 77 77 0.39 15.41 67.55
[-0.09,0.87] 0.009
0.108
Activation 12 251 248 0.41 35.05 68.62
[0.12,0.70] 0.000
0.006
Platelet concentr. recodified 3.49
0.026
<1x106/microL 6 99 91 0.14 5.19 3.61
[-0.11,0.39] 0.393
0.266
1x106/microL 5 155 155 0.70 24.15 83.43
[0.17,1.24] 0.000
0.010
N. of treatment 0.06
0.800
Double treatment 5 60 60 0.33 23.34 83.57
[-0.35,1.00] 0.000
0.342
Single treatment 13 268 265 0.42 26.40 54.55
[0.18,0.66] 0.009
0.001
k: number of studies; N1: sample size of PRP group; N2: sample size of control group; Hedge’s g: effect size, ES; 95% CI: confidence interval 95%; Sig.: statistical
significance in double tail; Q: index of heterogeneity Q; I2: index of heterogeneity I2; Contrast Q: ANOVA Q-test random-effects.
https://doi.org/10.1371/journal.pone.0191093.t003
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For multiple outcomes a conservative approach was adopted, in order to respect the com-
plexity of primary studies. Only at a later stage, an aggregation of outcomes was performed to
obtain a comprehensive synthesis of the results.
The overall findings of the meta-analysis are suggestive of a positive effect of PRP, but do
not support completely the hypothesis of superiority of the group treated with PRP compared
to the control group, since primary and combined outcome measures showed statistically sig-
nificant differences but secondary outcome measures did not.
The primary outcome evaluation (reduction of open wound area in PRP treated wounds
compared to controls) indicates a statistically significant difference between the study groups
with advantage of the treated group. This finding is associated with a moderate degree of het-
erogeneity. The quality of evidence obtained in the meta-analysis for the primary outcome was
demonstrated by sensitivity analysis, excluding alternately each of the studies, even showing
negative ES [51,53], null ES [30,46], or statistically positive ES [43,54,55,57]: no relevant
changes occurred in the results of the meta-analysis of primary outcome, persisting in statisti-
cal agreement with the hypothesis that supports the superiority of the PRP group. The sensitiv-
ity analysis finds its own indication in the identification of potential "outlier studies". This
term indicates studies whose results are extremely different from those reported in other stud-
ies. The result of primary outcome analysis is confirmed by the absence of evidence of risk of
publication bias.
The evaluation of outcome 2 (healing time) shows a heterogeneous balancing between stud-
ies that favoured PRP group and studies that favoured control group. Only one study reported
a significantly lower healing time in PRP group [48]. Both studies showing negative ES in this
outcome were performed on horses [47,53]. It is widely described in literature that second
intention wound healing in equidae may be more complicated than in other animal species.
The development of exuberant granulation tissue is a common cause of delayed healing in
equine limb wounds [76,77]. As reported by Monteiro et al., topical application of PRP in
small granulating wounds could favor an excessive formation of granulation tissue and delay
the healing of limb wounds in horses [53]. This aspect should be considered when planning
clinical trials or treatments in equine wounds. The results for outcome 2 are not affected by
risk of publication bias. Despite the high degree of heterogeneity, there were no outlier studies
for this outcome.
Considering the number of wounds completely healed in PRP group compared to control
group (number of healings, outcome 3), a condition of high heterogeneity is detected, as
indicated by the Q and I2 indices, and no significant difference between the two groups is
observed. The Dionyssiou et al. (2013) study [48] is significantly in favour of the treatment
with PRP; on the contrary, the study by Hadad et al. (2010) [49] is not-significantly in favor of
the control group. The analysis of publication bias was not possible for this outcome, since
only two primary studies are reported.
The general meta-analysis, obtained considering all the outcomes (primary and secondary),
shows a statistically significant difference between the two experimental groups with a moder-
ate degree of heterogeneity. The comprehensive meta-analysis agrees with the hypothesis that
supports a greater efficacy of the PRP treatment on the healing process of experimentally
induced wounds in animals. The sensitivity analysis confirms the quality of the evidence; in
fact, the exclusion of each of the primary experimental studies does not produce any changes
in the final results of the meta-analysis. The general absence of publication bias provides fur-
ther support to the quality of the evidence.
Both the secondary outcomes (healing time and number of healings) had a smaller impact
on the result of the combination of all outcomes than the primary outcome (reduction of
wound area). The much higher number of wounds and primary studies considered, as well as
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the higher number of calculated ES, explain the greater impact of the primary outcome on the
combined outcome and on the overall results of the meta-analysis.
The principal strengths of the study are the fairly high number of studies included in the
analysis and the general absence of publication bias. The main limitation relates to the modest
average number of wounds in the primary studies, the moderate/high degree of heterogeneity,
the variety of animal species considered, the type of control treatment and the fact that PRP is
a biologic product that, for its own nature, could lead to many uncontrollable variables.
In this systematic review, different animal species have been considered with the aim of
obtaining a global assessment of the effect of PRP on animals, but it could also be a limiting
factor since the different species may have different healing pattern.
In all included studies, control wounds underwent placebo application (saline solution,
milli-Q-water) or were left untreated. This aspect was not analyzed among moderators because
of the substantial homogeneity in the therapy of control group. However, it is necessary to rec-
ognize that comparing a therapy with sub-standard control treatment, such as placebo or non-
treatment, can lead to an overestimation of the effect of treatment under investigation. Future
prospective studies should compare PRP to therapies or advanced dressings that truly support
wound healing.
Several moderators were taken into consideration to explain the heterogeneity observed in
the studies included in the quantitative synthesis. These moderators included the country
where the study was performed (categorical moderator recoded at 4 levels by geographic area
corresponding to the continents). The animal species (dichotomous categorical moderator,
including rodent/lagomorph mammals and non-rodent/lagomorph mammals) was consid-
ered one of the main moderators because of the substantial differences amongst the animal
species considered. The initial wound size recodified (continuous moderator variable recoded
and expressed as a dichotomous variable, wound size < or 1 cm2) was considered because
it could potentially exert a great influence on the wound-healing process, though this could
not be confirmed in this meta-analysis. Current literature considers the source of funding as
one of many possible causes of bias in scientific research and associated with differences in
research report quality [78–80]. On that basis, the source of funding was analysed as modera-
tor (categorical moderator with three levels: for profit, for non-profit, and no-funding state-
ment) but it did not show any significant effect in this meta-analysis. Studies not reporting any
source of funding (n = 5) were considered as missing-data and were therefore excluded from
the analysis. Some important technical parameters of production process and therapeutic
application were considered as moderators, such as the number of spinning cycles used to
obtain the PRP (categorical moderator with two levels, single or double centrifugation); the
application of PRP activation procedures (categorical moderator with two levels, use or non-
use of PRP activation procedures); the PRP platelet concentration (continuous moderator vari-
able recoded and expressed as a dichotomous variable, concentration of platelets < or 1x106
/ microL); the number of treatments (categorical moderator with two levels, single or multiple
treatment). The most influential moderator was the PRP platelet concentration. Theoretical
and mathematical grounds justified the decision to recode this moderator. The theoretical
ground was motivated by the finding that some authors identified the concentration of 1x106
platelets/microL as a "reasonable compromise" of reference to determine the quality of the
product to obtain a therapeutic effect [81]. The mathematical ground was motivated to achieve
a uniform distribution rate of the studies in each of the recoded moderator levels. The analysis
showed a significant difference between the two categories in influencing the effect size; in
fact, the platelet concentration greater or equal to the recoded cut-off showed an effect size sig-
nificantly higher compared to the lower platelet concentration. Although a close linear correla-
tion has not been established [81,82], this finding seems to support the hypothesis of some
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authors who relate the platelet concentration to the clinical effect as it is positively correlated
with the concentration of growth factors [14,15,83]. Moreover, an excessively high platelet
concentration could be counterproductive to the healing process, as potentially able to inhibit
the angiogenic process [84]. The choice to use as moderator the platelet concentration in PRP
(reported by 11 studies [30,43,45–51,54,55]), instead of platelet fold increase from whole blood
to PRP (reported by 5 studies [44,45,51,53,54]), is supported by scientific literature [81]. Plate-
let concentration of normal whole blood could differ substantially between animal species,
therefore it seems reasonable to think that, considering only the fold increase in platelets, some
difficulties in standardisation of PRP and in interpretation of results may arise. The platelet
fold increase could be considered a first rough measure of the quality of the production pro-
cess; conversely, the platelet concentration could be considered a first rough measure of the
quality of the product (PRP) for clinical use. To fully interpret this aspect, any researcher carry-
ing out a study on PRP should report both of these data.
Five studies had a high risk of selection bias [30,43,44,48,57]; this result, however, must be
interpreted on the basis of the type of studies. Based on the inclusion criteria, experimental
clinical studies characterised by skin lesions induced in animals are considered in this review.
Each study presented an artificial-iatrogenic, experimental condition of homogeneity between
treated and control groups. In the 5 studies with a high risk of selection bias, this data was cor-
related to the lack of randomisation in the sequence generation, as the researchers arbitrarily
assigned experimental groups (i.e. left side wound always assigned to a control group, or vice
versa). This randomisation issue could be considered less influential in this type of study,
because they are performed on experimentally-induced injuries. On the other hand, clinical
trials are performed on patients with spontaneous lesions and usually start from a natural con-
dition of inhomogeneity in terms of quality and quantity of injuries; therefore, they require a
low selection bias to increase the clinical evidence and to be legitimately contemplated in a
meta-analysis.
Overall completeness and applicability of evidence
The use of PRP is undergoing a considerable increase in recent years, as evidenced by the
number of studies considered in this and other systematic reviews [85–90].
In this review, experimental skin lesions induced in animals were examined. This condition
undoubtedly presents a high level of experimental evidence, both at the beginning of the study
(since these lesions are substantially identical from a morphological and qualitative point of
view) and during the study, maintaining the same conditions of homogeneity between groups
during the follow-up. However, they are experimentally induced in healthy patients. There-
fore, they have to be considered acute lesions on an ideal substrate with normal healing poten-
tial conditions in which the advantage deriving from PRP might be rather limited in clinical
practice.
According to literature, clinical use of PRP in wounds could represent a benefit to patients
suffering from difficult-to-heal wounds. Although this type of injury was not the subject of this
meta-analysis, patients displaying chronic wounds, with poor healing tendencies (for example
wounds, sores and pressure ulcers, diabetic and vascular ulcers), which are systematically char-
acterised by a state of chronic inflammation and a GFs deficit [3,4], could benefit even more
from treatment with PRP [35,53]. In partial agreement with this hypothesis is a clinical study
performed in dogs with spontaneous chronic decubital wounds. The authors found that
wounds older than 14 weeks had a greater reduction in wound size after PRP treatment than
wounds that were<14 weeks. However, they did not find significant difference in complete
wound healing [35]. A systematic review reported a low quality of the evidence to suggest
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autologous PRP for treating human chronic wounds; current evidence is based on a small
number of randomised clinical trials with a high or unclear risk of bias, and concludes that
well-designed and adequately powered clinical trials are needed [90].
Potential biases in the review process
In some cases it was not possible to use the original data. Some authors did not provide the
requested data; therefore, only available data have been used for the effect size calculation. The
studies with a null effect size (ES = 0.00), to which an input significance P = 1.0 was attributed
[30,46], were anyway considered in the quantitative analysis following the more conservative
approach to data. The overall results of the meta-analysis were not substantially affected by
these studies, as shown by the sensitivity analysis performed on each primary, secondary and
aggregate outcome.
Conclusions
Implications for practice
The overall findings of this systematic review are suggestive of a positive effect of PRP in the
treatment of experimentally-induced skin wounds, but do not support completely the hypoth-
esis of superiority of the group treated with PRP compared to the control group. Wound area
reduction and combined outcome measures were positively affected by PRP, while healing
time and number of healed wounds were not. PRP can be considered an effective adjunctive
therapy in stimulating second intention healing of acute wounds in healthy animals. PRP-
products containing concentrations of platelets1x106/microL seem to have better effect than
those with lower concentrations.
Implication for research
Based on the results of this systematic review, well-designed, large-scale RCT on spontaneous
wounds are needed to determine whether using PRP represents a benefit in clinical conditions.
In such clinical studies, it will be necessary to define some key elements for the interpretation
of results, such as the technique used for PRP production and activation, method and time of
administration and characteristics of the lesion. Currently in veterinary medicine, there is only
one RCT performed using PRP on chronic pressure ulcers in dogs [35] and the results are very
encouraging. In addition to the studies on acute and chronic spontaneous wounds, more clini-
cal trials on patients affected by conditions of wound healing difficulties, such as endocrine
disorders, degenerative diseases, cytostatic and corticosteroid therapies, may provide addi-
tional and valuable evidence on the use of PRP in veterinary medicine.
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